HarbourVest leads China GP-led on Baidu, Tencent backer
IDG Capital, which has $20bn in assets, is understood to have run a novel yuan-to-dollar secondaries process advised by Lazard.
Pantheon, LGT back early-stage biotech restructuring
The deal involving Medicxi was based around six assets and completed at a premium to NAV, co-founder Francesco De Rubertis told Secondaries Investor.
Northleaf’s GP-stakes-like deal to pave the way for succession
Managing director Jeff Pentland says the firm wants to start thinking about succession planning now rather than in a decade.
LP liquidity concerns have evaporated – Campbell Lutyens
The proportion of respondents who are 'not concerned' about liquidity was 81% across the summer, compared with 46% in the spring, according to a survey by the advisory firm.
Oregon pension shops $1.5bn portfolio of PE stakes
The US pension had set up a partnership with Pathway Capital Management last year to sell fund stakes.
Q&A: LACERA on buying in the secondaries market
The $60bn US pension backed the Revelstoke and Accel-KKR GP-led deals last year and expects to invest in more before the year is out.
Pricing rebounds from pandemic-inflicted lows – Setter
The average high bid for buyout funds surpassed 90% of NAV in the three months to end-August, according to data from the intermediary.
Liberty Street takes control of $200m VC secondaries fund
The SharesPost100 fund, designed to democratise access to VC, is managed by ex-HQ Capital secondaries co-head Christian Munafo.
The GP-led market is back, but not as we know it
An apparent flurry of dealflow doesn’t mean they will all get across the line
Adams Street: Buyers must adjust to new risk environment
Strategies that worked well for buyers during the bull market may no longer work, says the investment firm's head of secondaries Jeff Akers.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: